Recent update on XBB.1.5 emerging novel mutation of COVID-19

被引：1
|
作者：
Amin, Ruhul [1 ]
Pal, Prosanta [2 ]
Dhama, Kuldeep [3 ]
Emran, Talha B. [4 ,5 ,6 ]
机构：
[1] Assam Down Town Univ, Fac Pharmaceut Sci, Gauhati, Assam, India
[2] Univ North Bengal, Dept Pharmaceut Technol, Darjeeling, West Bengal, India
[3] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India
[4] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong, Bangladesh
[5] Daffodil Int Univ, Fac Allied Hlth Sci, Dept Pharm, Dhaka, Bangladesh
[6] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4381, Bangladesh
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2023年 / 109卷 / 04期
关键词：
D O I：
10.1097/JS9.0000000000000254
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1048 / 1049
页数：2
相关论文
共 50 条
  • [21] Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines
    Lustig, Yaniv
    Barda, Noam
    Weiss-Ottolenghi, Yael
    Indenbaum, Victoria
    Margalit, Ili
    Asraf, Keren
    Doolman, Ram
    Chalkias, Spyros
    Das, Rituparna
    Elfatarany, Gamal
    Harats, Dror
    Kreiss, Yitshak
    Regev-Yochay, Gili
    VACCINE, 2024, 42 (22)
  • [22] Smouldering COVID-19 XBB.1.5. subvariant pneumonitis: a case report
    Davison, Sara
    Kanitkar, Tanmay
    Menouhos, Dimitrios
    Ewin, Thomas
    Marshall, Catherine S.
    Boan, Peter
    Janson, Sonja
    MEDICAL JOURNAL OF AUSTRALIA, 2024, 221 (05) : 244 - 245
  • [23] Recent Update of COVID-19 Vaccines
    Jadaan, Sameer A.
    Khan, Abdul Waheed
    ADVANCED PHARMACEUTICAL BULLETIN, 2022, 12 (02) : 219 - 236
  • [24] Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up A Target Trial Emulation
    Ioannou, George N.
    Berry, Kristin
    Rajeevan, Nallakkandi
    Li, Yuli
    Yan, Lei
    Huang, Yuan
    Lin, Hung-Mo
    Bui, David
    Hynes, Denise M.
    Rowneki, Mazhgan
    Bohnert, Amy
    Boyko, Edward J.
    Iwashyna, Theodore J.
    Maciejewski, Matthew L.
    Smith, Valerie A.
    Berkowitz, Theodore S. Z.
    O'Hare, Ann M.
    Viglianti, Elizabeth M.
    Aslan, Mihaela
    Bajema, Kristina L.
    ANNALS OF INTERNAL MEDICINE, 2025,
  • [25] Comparative effectiveness of monovalent XBB.1.5 containing covid-19 mRNA vaccines in Denmark, Finland, and Sweden: target trial emulation based on registry data
    Andersson, Niklas Worm
    Thiesson, Emilia Myrup
    Pihlstrom, Nicklas
    Perala, Jori
    Faksova, Kristyna
    Gram, Mie Agermose
    Poukka, Eero
    Leino, Tuija
    Ljung, Rickard
    Hviid, Anders
    BMJ MEDICINE, 2024, 3 (01):
  • [26] Neutralization of SARS-CoV-2 Omicron XBB.1.5 and JN.1 variants after COVID-19 booster-vaccination and infection
    Springer, David N.
    Camp, Jeremy V.
    Aberle, Stephan W.
    Deutsch, Josef
    Lammel, Oliver
    Weseslindtner, Lukas
    Stiasny, Karin
    Aberle, Judith H.
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (07)
  • [27] Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023
    van Werkhoven, C. Henri
    Valk, Anne-Wil
    Smagge, Bente
    de Melker, Hester E.
    Knol, Mirjam J.
    Hahne, Susan J. M.
    van den Hof, Susan
    de Gier, Brechje
    EUROSURVEILLANCE, 2024, 29 (01)
  • [28] An update on emerging therapeutics to combat COVID-19
    Shah, Naveed Nazir
    Nabi, Showkat Ul
    Rather, Muzafar Ahmad
    Kalwar, Qudratullah
    Ali, Sofi Imtiyaz
    Sheikh, Wajid Mohammad
    Ganai, Alveena
    Bashir, Showkeen Muzamil
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 129 (02) : 104 - 129
  • [29] Boosting effects of additional mRNA COVID-19 vaccine given after one year in adults previously received two doses inactivated COVID-19 vaccines with third dose of any COVID-19 vaccine during Omicron XBB.1.5
    Muangnoicharoen, Sant
    Lawpoolsri, Saranath
    Jongkaewwattana, Anan
    Nanthapisal, Sira
    Duangdee, Chatnapa
    Kamolratanakul, Supitcha
    Luvira, Viravarn
    Thanthamnu, Narumon
    Pitisuttithum, Punnee
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [30] Pre-exposure prophylaxis for COVID-19 with Tixagevimab/Cilgavimab in kidney transplant recipients in the Kraken variant (XBB.1.5) era: A Single-center Experience
    Pinchera, Biagio
    Carrano, Rosa
    Salemi, Fabrizio
    Piccione, Amerigo
    Schettino, Elisa
    Romano, Paolo
    Trucillo, Emilia
    D'Agostino, Alessia
    Sarno, Marina
    Zappulo, Emanuela
    Gentile, Ivan
    NEW MICROBIOLOGICA, 2024, 47 (03): : 265 - 268
12345